These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 22392809)
21. Recent progress in the discovery and development of negative allosteric modulators of mGluR5. Lindsley CW; Emmitte KA Curr Opin Drug Discov Devel; 2009 Jul; 12(4):446-57. PubMed ID: 19562641 [TBL] [Abstract][Full Text] [Related]
22. Chemical screening in zebrafish for novel biological and therapeutic discovery. Tan JL; Zon LI Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544 [TBL] [Abstract][Full Text] [Related]
23. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer. Verma SK; Knight SD Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271 [TBL] [Abstract][Full Text] [Related]
24. Screening and profiling assays for HDACs and sirtuins. Howitz KT Drug Discov Today Technol; 2015 Nov; 18():38-48. PubMed ID: 26723891 [TBL] [Abstract][Full Text] [Related]
25. Design of small molecule epigenetic modulators. Pachaiyappan B; Woster PM Bioorg Med Chem Lett; 2014 Jan; 24(1):21-32. PubMed ID: 24300735 [TBL] [Abstract][Full Text] [Related]
26. Targeting epigenetic reader domains by chemical biology. Cipriano A; Sbardella G; Ciulli A Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717 [TBL] [Abstract][Full Text] [Related]
27. Make way for the 'next generation': application and prospects for genome-wide, epigenome-specific technologies in endocrine research. Emes RD; Farrell WE J Mol Endocrinol; 2012 Aug; 49(1):R19-27. PubMed ID: 22525352 [TBL] [Abstract][Full Text] [Related]
32. Target identification of bioactive compounds. Tashiro E; Imoto M Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438 [TBL] [Abstract][Full Text] [Related]
33. Increasing the delivery of next generation therapeutics from high throughput screening libraries. Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818 [TBL] [Abstract][Full Text] [Related]
34. Small-world phenomena in chemical library networks: application to fragment-based drug discovery. Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207 [TBL] [Abstract][Full Text] [Related]
35. Drug discovery with DNA-encoded chemical libraries. Buller F; Mannocci L; Scheuermann J; Neri D Bioconjug Chem; 2010 Sep; 21(9):1571-80. PubMed ID: 20681509 [TBL] [Abstract][Full Text] [Related]
36. Fragment-based ligand discovery. Fischer M; Hubbard RE Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661 [TBL] [Abstract][Full Text] [Related]
37. 20 years of DNA-encoded chemical libraries. Mannocci L; Leimbacher M; Wichert M; Scheuermann J; Neri D Chem Commun (Camb); 2011 Dec; 47(48):12747-53. PubMed ID: 22083211 [TBL] [Abstract][Full Text] [Related]
38. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery? Thiel P; Kaiser M; Ottmann C Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055 [TBL] [Abstract][Full Text] [Related]
39. Unbiased binding assays for discovering small-molecule probes and drugs. Kemp MM; Weïwer M; Koehler AN Bioorg Med Chem; 2012 Mar; 20(6):1979-89. PubMed ID: 22230199 [TBL] [Abstract][Full Text] [Related]